Cited by

• Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI.

  Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative. Shaw LM, et al. Acta Neuropathol. 2011 May;121(5):597-609. doi: 10.1007/s00401-011-0808-0. Epub 2011 Feb 11. Acta Neuropathol. 2011. PMID: 21311900 Free PMC article.
• Altered DNA base excision repair profile in brain tissue and blood in Alzheimer's disease.

  Lillenes MS, Rabano A, Støen M, Riaz T, Misaghian D, Møllersen L, Esbensen Y, Günther CC, Selnes P, Stenset VT, Fladby T, Tønjum T. Lillenes MS, et al. Mol Brain. 2016 May 28;9(1):61. doi: 10.1186/s13041-016-0237-z. Mol Brain. 2016. PMID: 27234294 Free PMC article.
• Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

  Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative. Trojanowski JQ, et al. Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Alzheimers Dement. 2010. PMID: 20451871 Free PMC article. Review.
• The Role of PICALM in Alzheimer's Disease.

  Xu W, Tan L, Yu JT. Xu W, et al. Mol Neurobiol. 2015 Aug;52(1):399-413. doi: 10.1007/s12035-014-8878-3. Epub 2014 Sep 4. Mol Neurobiol. 2015. PMID: 25186232 Review.
• Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.

  White MT, Shaw LM, Xie SX; Alzheimer’s Disease Neuroimaging Initiative; National Alzheimer’s Coordinating Center. White MT, et al. J Alzheimers Dis. 2016;51(2):463-70. doi: 10.3233/JAD-151045. J Alzheimers Dis. 2016. PMID: 26890778 Free PMC article.